ResMetrix Medical

Resmetrix Medical has developed a wearable technology designed to monitor patients with asthma and COPD in order to provide early warning of episodes. The companys solution also immediately notifies clinicians if the patients condition worsens, enabling rapid medical intervention with the aim of preventing hospitalization. The Resmetrix wearable respiratory monitoring system consists of a sensor integrated into a comfortable chest strap or patch that continuously and accurately monitors the patients respiratory patterns, regardless of the individuals location or activity. The device wirelessly connects to a smartphone app that displays the patients respiratory parameters and vital signs in real time and can communicate exacerbations early, ensuring rapid attention and clinician response. The Resmetrix system utilizes an AI-powered algorithm that assesses disease progression based on the patients breathing patterns and trends. The device is seamless to the patient, requiring no interaction or management to enable its continuous monitoring of lung performance and other related health indicators.

ResMetrix Medical has raised $750K in total funding across 1 rounds. The company is currently at the Seed stage. Key investors include Israel Innovation Authority, MindUP.

ResMetrix Medical was founded in 2017 by Ari DeRowe (Co-founder & MD), Zvi Reznic (Co-founder & Technical Advisor).

ResMetrix Medical operates in Health Tech & Life Sciences, Digital Healthcare, Patient Remote Monitoring, with core technologies in Sensing, Semiconductors & Electronics, Wearables. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

ResMetrix Medical is based in Netiv HaOr 1, Haifa, Israel, North District.